Evaluates plasma cfDNA for identifying endocarditis in lung transplant recipients, suggesting improved early detection.
Scedosporium apiospermum is an emerging cause of invasive mold infection in immunocompromised hosts, often with central nervous system involvement and limited susceptibility to amphotericin B. We describe a 36‐year‐old lung transplant recipient who presented with fever, meningismus, and multiple enhancing brain lesions nine months post‐transplant. Cerebrospinal fluid studies, including metagenomic next‐generation sequencing (mNGS), were negative. Cardiac imaging revealed a pedunculated right ventricular septal mass, and plasma cell‐free DNA (cfDNA) testing (Karius) identified S. apiospermum . Subsequent brain biopsy and thrombectomy confirmed the diagnosis by histopathology and culture. Following surgical removal of the cardiac mass and treatment with voriconazole, the patient improved with near resolution of brain lesions. This case highlights disseminated S. apiospermum endocarditis diagnosed by plasma cfDNA despite negative CSF mNGS, underscoring that site‐specific mNGS may be falsely negative in compartmentalized infections. Plasma cfDNA testing can complement conventional and tissue‐based diagnostics for early detection of disseminated mold infections in transplant recipients.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: